Victrex (LON:VCT) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says

Victrex (LON:VCT) had its target price upped by stock analysts at JPMorgan Chase & Co. from GBX 625 to GBX 785 in a research report issued on Thursday, London Stock Exchange reports. The brokerage currently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price objective indicates a potential downside of 21.68% from the stock’s current price.

A number of other research analysts also recently issued reports on the company. Jefferies Financial Group reaffirmed a “hold” rating and set a GBX 595 price target on shares of Victrex in a report on Tuesday, July 7th. Berenberg Bank lifted their price objective on Victrex from GBX 600 to GBX 680 and gave the stock a “hold” rating in a report on Wednesday, July 8th. Finally, Canaccord Genuity Group lowered Victrex to a “buy” rating and set a GBX 725 target price for the company. in a research report on Friday, May 15th. One investment analyst has rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of GBX 690.

Victrex Trading Down 0.8%

Shares of LON VCT opened at GBX 1,002.34 on Thursday. The firm’s 50 day moving average price is GBX 777.33 and its 200-day moving average price is GBX 671.57. Victrex has a 52-week low of GBX 515 and a 52-week high of GBX 1,024. The company has a debt-to-equity ratio of 21.30, a quick ratio of 1.99 and a current ratio of 2.35. The company has a market cap of £873.60 million, a PE ratio of -44.75, a P/E/G ratio of 1.92 and a beta of 0.82.

Victrex Company Profile

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.